# Aurinia Pharmaceuticals Inc.: Form 8-K, filed Sep 21, 2023

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: 8-K
- Filed: 2023-09-21
- Accepted by EDGAR: Sep 21, 2023, 16:06 ET
- Period: 2023-09-21
- Accession: 0001600620-23-000040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000040/auph-20230921.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000040/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062023000040/auph-20230921.htm

Filed Sep 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001600620-23-000040. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.